Ondansetron for the Treatment of Methamphetamine Dependence - 1

Completed · Phase 2

Conditions studied: Amphetamine-Related Disorders

In brief

The purpose of this study is to assess ondansetron for the treatment of methamphetamine dependence.

Key facts

Study ID

NCT00040053

Run by

National Institute on Drug Abuse (NIDA)

People needed

154

Starts

2002-06-01

Expected to finish

2004-02-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age. Treatment seeking for meth dependence.

You may not qualify if…

• Please contact site director for more details.

Where it is running

• South Bay Treatment Center — Chula Vista, California, United States
• Matrix Institute on Addictions — Costa Mesa, California, United States
• John A. Burns School of Medicine — Honolulu, Hawaii, United States
• Powell Chemical Dependency Center — Des Moines, Iowa, United States
• University of Missouri - Kansas City — Kansas City, Missouri, United States
• University of Texas Health Science Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.